APA-referens

Akamatsu, K., Matsunaga, K., Sugiura, H., Koarai, A., Hirano, T., Minakata, Y., & Ichinose, M. (2011). Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker? Frontiers Research Foundation.

Chicago-stil citat

Akamatsu, Keiichiro, Kazuto Matsunaga, Hisatoshi Sugiura, Akira Koarai, Tsunahiko Hirano, Yoshiaki Minakata, och Masakazu Ichinose. Improvement of Airflow Limitation By Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What Is the Specific Marker? Frontiers Research Foundation, 2011.

MLA-referens

Akamatsu, Keiichiro, et al. Improvement of Airflow Limitation By Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What Is the Specific Marker? Frontiers Research Foundation, 2011.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.